Photo from Akash Maniam/LinkedIn
May 23, 2024, 11:22
Akash Maniam: The world of managing HR+ breast cancer has become so amazingly complex in such a short space of time
Akash Maniam, Medical Oncologist at
“Phase II IO + PARPi + endocrine therapy combination data for advanced HR+ breast cancer – durvalumab + olaparib + fulvestrant.
The world of managing HR+ breast cancer has become so amazingly complex in such a short space of time.
Nearly impossible to keep up but I absolutely love it!”
Source: Akash Maniam/LinkedIn